Prostate cancer

Effects of monomethoxypolyethylene glycol-chitosan nanoparticle-mediated dual silencing of livin and survivin genes in prostate cancer PC-3M cells

A. Q. Yang, Wang, P. J., Huang, T., Zhou, W. L., Landman, J., Yang, A. Q., Wang, P. J., Huang, T., Zhou, W. L., Landman, J., Yang, A. Q., Wang, P. J., Huang, T., Zhou, W. L., and Landman, J., Effects of monomethoxypolyethylene glycol-chitosan nanoparticle-mediated dual silencing of livin and survivin genes in prostate cancer PC-3M cells, vol. 15, p. -, 2016.

Monomethoxypolyethylene glycol-chitosan (mPEG-CS) nanoparticles were used as interfering RNA carriers to transfect human prostate cancer PC-3M cells to evaluate the effects of livin and survivin gene silencing on the proliferation and apoptosis. mPEG-CS nanoparticles with sizes of approximately 60 nm were first synthesized by ionic crosslinking. Through electrostatic adsorption, mPEG-CS-livin short hairpin RNA (shRNA), mPEG-CS-survivin shRNA, and mPEG-CS-(livin shRNA + survivin shRNA) nanoparticles were then prepared to transfect PC-3M cells.

Relationship between CYP17 gene polymorphisms and risk of prostate cancer

J. Song, Tao, Z. - H., Liu, X. - Y., Gong, S., Gan, L., Song, J., Tao, Z. - H., Liu, X. - Y., Gong, S., and Gan, L., Relationship between CYP17 gene polymorphisms and risk of prostate cancer, vol. 15, p. -, 2016.

Cytochrome P450 17a-hydroxylase (CYP17) plays a critical role in androgen biosynthesis. Polymorphisms of the CYP17 promoter have been proposed as risk factors for prostate cancer; however, some studies have produced inconclusive or controversial results. We investigated the relationship between polymorphisms of the CYP17 gene and the risk of prostate cancer. A total of 176 patients with prostate cancer were enrolled in the study, and 168 healthy individuals acted as the control group. The participants were divided into those CYP17 in the samples.

Influence of suppression of CapG gene expression by siRNA on the growth and metastasis of human prostate cancer cells

B. K. Li, Guo, K., Li, C. Y., Li, H. L., Zhao, P. P., Chen, K., and Liu, C. X., Influence of suppression of CapG gene expression by siRNA on the growth and metastasis of human prostate cancer cells, vol. 14, pp. 15769-15778, 2015.

This study investigated CapG gene expression in prostate cancer cell lines; in addition, we explored the effects of CapG suppression on DU145 cell growth, and the underlying mechanism with which CapG affects DU145 cell growth and invasiveness. The expression of CapG and 18 related genes in DU145 cells was analyzed by flow cytometry, quantitative polymerase chain reaction (qPCR), CCK8 assay, western blot, and the trans-well assay. DU145 cells were transfected with designed small interfering RNA (siRNA). CapG expression was quantified by qPCR and western blot.

Effect of siRNA targeting HER2/neu on the proliferation and viability of prostate cancer PC-3M cells

C. Y. Liu, Xu, P. C., Chen, D. G., Fan, X. H., Li, M. Q., Yang, X., and Xu, Y. P., Effect of siRNA targeting HER2/neu on the proliferation and viability of prostate cancer PC-3M cells, vol. 14, pp. 17145-17153, 2015.

The aim of this study was to investigate the effect of a small interfering RNA (siRNA) targeting human epidermal growth factor receptor 2 (HER2/neu) on the proliferation and viability of prostate cancer PC-3M cells. Chemically synthesized siRNA targeting HER2/neu was transfected into PC-3M cells by using liposomes, and cells transfected with empty liposomes, a negative siRNA sequence, or nothing (untransfected) were used as controls. mRNA and protein levels of HER2/neu were detected using reverse transcription-polymerase chain reaction and western blot, respectively.

Association between the 8q24 rs6983267 T/G polymorphism and prostate cancer risk: a meta-analysis

H. S. Zhu, Zhang, J. F., Zhou, J. D., Zhang, M. J., and Hu, H. X., Association between the 8q24 rs6983267 T/G polymorphism and prostate cancer risk: a meta-analysis, vol. 14, pp. 19329-19341, 2015.

Recent studies have indicated that single nucleotide polymorphisms (SNPs) within the 8q24 region may be a risk factor for prostate cancer (PCa). Here, we performed a meta-analysis to evaluate the association between the 8q24 rs6983267 T/G polymorphism and PCa risk. A systematic literature search was carried out in multiple electronic databases independently by two investigators. Pooled odds ratios (ORs) and 95% confidence intervals for 8q24 rs6983267 T/G and PCa were calculated using a fixed-effect model (the Mantel-Haenszel method).

Genetic polymorphism in sex hormone metabolism and prostate cancer risk

E. Ersekerci, Sofikerim, M., Taheri, S., Demirtas, A., and Halis, F., Genetic polymorphism in sex hormone metabolism and prostate cancer risk, vol. 14, pp. 7326-7334, 2015.

We compared single-nucleotide polymorphisms for point mutations in cytochrome P450 genes, including cytochrome P450c17α (CYP17), cytochrome P450 aromatase (CYP19), steroid-5-a-reductase (SRD5A2), and prostate-specific antigen (PSA) involved in androgen and estrogen production. Between January 2008 and January 2010, 90 patients were enrolled in the study. Of these patients, 28 were diagnosed with benign prostatic hyperplasia and 32 with prostate cancer, while 30 subjects were included as a control group.

Meta-analysis of the association between the HNF1B rs4430796 (A>G) polymorphism and risk of prostate cancer based on case-control studies

Y. Zhao, Liang, J., Qi, J. G., Yang, N., Wu, G., Lin, Y. L., Cao, J. Y., Wang, Q., and Wang, Q. C., Meta-analysis of the association between the HNF1B rs4430796 (A>G) polymorphism and risk of prostate cancer based on case-control studies, vol. 14, pp. 7426-7435, 2015.

Genome-wide studies have reported an association between the HNF1B rs4430796 (A>G) polymorphism and prostate cancer risk, but results have been inconsistent and recent meta-analyses have been inadequate. This study aimed to integrate previous results and explore the validity of this association. Electronic searches for all relevant publications through May 18, 2014, were conducted across several databases. Additional studies were identified manually, and only the most recent or complete were used in this meta-analysis.

Subscribe to Prostate cancer